Haris Ali

38PUBLICATIONS
137CO-AUTHORS
HaematologyRegenerative medicine (incl. stem cells)Molecular targetsTransplantation immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Jul 04, 2026
CHIME: a novel HLA eplet model associates with non-relapse mortality in haploidentical hematopoietic cell transplant with post-transplant cyclophosphamide.

|Jun 25, 2026
Donor Selection and Human Leukocyte Antigen Loss Leukemia Relapse After Hematopoietic Cell Transplantation.

|Jun 02, 2026
Selinexor Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Myelofibrosis: Phase III SENTRY Trial.

|Mar 05, 2026
Selinexor plus ruxolitinib in JAK inhibitor-naïve patients with myelofibrosis: a multicenter, open-label, phase 1 study.

Haris Ali, Sanjay Ram Mohan, Ashwin Kishtagari

|Nov 18, 2025
Long-term survival outcomes of allo-HCT in AML with fludarabine/melphalan conditioning and tacrolimus/sirolimus GVHD prophylaxis.

Amandeep Salhotra, Dongyun Yang, Monzr M Al Malki

|Feb 27, 2025
Melphalan-based conditioning with post-transplant cyclophosphamide for peripheral blood stem cell transplantation: donor effect.

Paul B Koller, Tamer Othman, Dongyun Yang

Pageof 7

Frequent Collaborators

21 joint publications

Monzr M Al Malki

17 joint publications

Ryotaro Nakamura

11 joint publications

Ibrahim Aldoss

11 joint publications

Shukaib Arslan